Merck KGaA to Close Merck Serono Site in Geneva, Cut Jobs

A A
Merck plans to close the Geneva headquarters of its Serono unit, five years after buying Europe’s biggest biotechnology company for about $13.3 billion to expand a drug business that has since faced development and regulatory setbacks.
Bloomberg